Daewoong Pharmaceutical
South Korean pharmaceutical company with commercial and clinical programs in gastroenterology, metabolic disease and dermatology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Not Yet Recruiting · Glabellar Lines
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy VolunteersPhase 1 · Recruiting · Healthy Subjects
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaNA · Recruiting · Diabetes Mellitus, Type 2
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.Phase 1 · Recruiting · Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting ConditionsPhase 1 · Recruiting · Healthy Volunteers
Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment PatientsPhase 3 · Not Yet Recruiting · Type 2 Diabetic Nephropathy
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/daewoong-pharmaceutical/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.